Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xencor Inc (XNCR)

Xencor Inc (XNCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xencor Inc 465 NORTH HALSTEAD STREET SUITE 200 PASADENA CA 91107 USA

www.xencor.com Employees: 260 P: 626-305-5900

Sector:

Medical

Description:

Xencor Inc. is a clinical-stage biopharmaceutical company. It develops antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Xencor Inc. is based in Monrovia, California.

Key Statistics

Overview:

Market Capitalization, $K 837,531
Enterprise Value, $K 903,211
Shares Outstanding, K 73,339
Float, K 69,848
% Float 95.24%
Short Interest, K 11,238
Short Float 15.32%
Days to Cover 17.88
Short Volume Ratio 0.46
% of Insider Shareholders 4.76%

Financials:

Annual Sales, $ 125,580 K
Annual Net Income, $ -91,920 K
Last Quarter Sales, $ 28,240 K
Last Quarter Net Income, $ -6,650 K
EBIT, $ -177,500 K
EBITDA, $ -170,470 K

Growth:

1-Year Return -0.78%
3-Year Return -59.05%
5-Year Return -73.43%
5-Year Revenue Growth 2.36%
5-Year Earnings Growth -2.48%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.09 on 02/25/26
Next Earnings Date 05/06/26
Earnings Per Share ttm -1.24
EPS Growth vs. Prev Qtr -12.50%
EPS Growth vs. Prev Year 85.48%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

XNCR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -14.58%
Return-on-Assets % -10.42%
Profit Margin % -73.20%
Debt/Equity 0.19
Price/Sales 7.19
Price/Cash Flow N/A
Price/Book 1.38
Book Value/Share 8.90
Interest Coverage -1.81
60-Month Beta 0.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.